Efficacy of Benidipine, a Long-acting Dihydropyridine Calcium Channel Blocker, for Dilated Cardiomyopathy Patients with Coronary Vasospasm
Not Applicable
Recruiting
- Conditions
- dilated cardiomyopathy
- Registration Number
- JPRN-UMIN000021961
- Lead Sponsor
- Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have ischemic heart disease, valvular disease, acute myocarditis, and secondary cardiomyopathy 2) Patients who have been taking calcium channel blocker 3) Patients in unstable status with symptoms of NYHA 4 4) Patients having serious liver dysfunction or having serious renal dysfunction requiring hemodialysis 5) Patients who are intolerant to dihydropyridine calcium channel blocker 6) Patients with a contraindication to dihydropyridine calcium channel blocker 7) Patients who are pregnant 8) Patients who did not consent to the trial 9) Patients who were considered as inappropriate candidates for the trial by phsicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ejection Fraction at 6 months after the initiation of the treatment
- Secondary Outcome Measures
Name Time Method